Research Gap: While skin boosters (hyaluronic acid-based treatments) are primarily used for hydration and fine lines, their impact on hyperpigmentation, particularly in darker skin tones (Fitzpatrick types IV–VI), remains unexplored.
Objective:
- Assess the efficacy of skin boosters in reducing pigmentation caused by melasma, post-inflammatory hyperpigmentation (PIH), or age spots.
- Investigate mechanisms of action: does enhanced hydration and dermal plumping affect melanin distribution?
Methodology:
- Conduct a randomized controlled trial comparing skin booster treatments with conventional hyperpigmentation therapies (like chemical peels or topical vitamin C).
- Evaluate melanin density and skin tone uniformity using dermoscopic imaging and spectroscopy over 6–12 months.
Impact: This research could expand the application of skin boosters, addressing unique dermatological concerns of darker skin tones often overlooked in cosmetic dermatology studies.